Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 404

1.

Jules Dejerine and the peripheral nervous system.

Mathis S, Vallat JM.

Neurology. 2017 Aug 8;89(6):611-615. doi: 10.1212/WNL.0000000000004217.

PMID:
28784633
2.

Bovine and murine models highlight novel roles for SLC25A46 in mitochondrial dynamics and metabolism, with implications for human and animal health.

Duchesne A, Vaiman A, Castille J, Beauvallet C, Gaignard P, Floriot S, Rodriguez S, Vilotte M, Boulanger L, Passet B, Albaric O, Guillaume F, Boukadiri A, Richard L, Bertaud M, Timsit E, Guatteo R, Jaffrézic F, Calvel P, Helary L, Mahla R, Esquerré D, Péchoux C, Liuu S, Vallat JM, Boichard D, Slama A, Vilotte JL.

PLoS Genet. 2017 Apr 4;13(4):e1006597. doi: 10.1371/journal.pgen.1006597. eCollection 2017 Apr.

3.

CNTNAP1 mutations cause CNS hypomyelination and neuropathy with or without arthrogryposis.

Hengel H, Magee A, Mahanjah M, Vallat JM, Ouvrier R, Abu-Rashid M, Mahamid J, Schüle R, Schulze M, Krägeloh-Mann I, Bauer P, Züchner S, Sharkia R, Schöls L.

Neurol Genet. 2017 Mar 22;3(2):e144. doi: 10.1212/NXG.0000000000000144. eCollection 2017 Apr.

4.

Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.

Maddur MS, Stephen-Victor E, Das M, Prakhar P, Sharma VK, Singh V, Rabin M, Trinath J, Balaji KN, Bolgert F, Vallat JM, Magy L, Kaveri SV, Bayry J.

J Neuroinflammation. 2017 Mar 20;14(1):58. doi: 10.1186/s12974-017-0818-5.

5.

Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome.

Mathis S, Magy L, Corcia P, Ghorab K, Richard L, Ciron J, Duchesne M, Vallat JM.

Case Rep Neurol Med. 2016;2016:6108234. doi: 10.1155/2016/6108234. Epub 2016 Dec 1.

6.

Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies.

Vallat JM, Yuki N, Sekiguchi K, Kokubun N, Oka N, Mathis S, Magy L, Sherman DL, Brophy PJ, Devaux JJ.

Neuromuscul Disord. 2017 Mar;27(3):290-293. doi: 10.1016/j.nmd.2016.10.008. Epub 2016 Oct 24.

PMID:
27986399
7.

Contactin-Associated Protein 1 (CNTNAP1) Mutations Induce Characteristic Lesions of the Paranodal Region.

Vallat JM, Nizon M, Magee A, Isidor B, Magy L, Péréon Y, Richard L, Ouvrier R, Cogné B, Devaux J, Zuchner S, Mathis S.

J Neuropathol Exp Neurol. 2016 Dec 1;75(12):1155-1159. doi: 10.1093/jnen/nlw093.

PMID:
27818385
8.

Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.

Leys D, Hommet Y, Jacquet C, Moulin S, Sibon I, Mas JL, Moulin T, Giroud M, Sagnier S, Cordonnier C, Medeiros de Bustos E, Turc G, Ronzière T, Bejot Y, Detante O, Ouk T, Mendyk AM, Favrole P, Zuber M, Triquenot-Bagan A, Ozkul-Wermester O, Montoro FM, Lamy C, Faivre A, Lebouvier L, Potey C, Poli M, Hénon H, Renou P, Dequatre-Ponchelle N, Bodenant M, Debruxelles S, Rossi C, Bordet R, Vivien D; OPHELIE investigators and the STROKAVENIR network.

Neurology. 2016 Dec 6;87(23):2416-2426. Epub 2016 Nov 4.

PMID:
27815401
9.

Two novel variants in CNTNAP1 in two siblings presenting with congenital hypotonia and hypomyelinating neuropathy.

Nizon M, Cogne B, Vallat JM, Joubert M, Liet JM, Simon L, Vincent M, Küry S, Boisseau P, Schmitt S, Mercier S, Bénéteau C, Larrose C, Coste M, Latypova X, Péréon Y, Mussini JM, Bézieau S, Isidor B.

Eur J Hum Genet. 2016 Jan;25(1):150-152. doi: 10.1038/ejhg.2016.142. Epub 2016 Oct 26.

PMID:
27782105
10.

Sensory neuropathy in progressive motor neuronopathy (pmn) mice is associated with defects in microtubule polymerization and axonal transport.

Schäfer MK, Bellouze S, Jacquier A, Schaller S, Richard L, Mathis S, Vallat JM, Haase G.

Brain Pathol. 2017 Jul;27(4):459-471. doi: 10.1111/bpa.12422. Epub 2016 Oct 18.

PMID:
27488538
11.

Management and therapeutic perspectives in amyotrophic lateral sclerosis.

Mathis S, Couratier P, Julian A, Vallat JM, Corcia P, Le Masson G.

Expert Rev Neurother. 2017 Mar;17(3):263-276. doi: 10.1080/14737175.2016.1227705. Epub 2016 Sep 20. Review.

PMID:
27644548
12.

Monoclonal gammopathy of undeterminated significance and endoneurial IgG deposition: A case report.

Mathis S, Franques J, Richard L, Vallat JM.

Medicine (Baltimore). 2016 Sep;95(36):e4807. doi: 10.1097/MD.0000000000004807.

13.

Reasons Charcot-Marie-Tooth disease due to mutations in the MME gene should not be named AR-CMT2T.

Mathis S, Goizet C, Tazir M, Magy L, Vallat JM.

Ann Neurol. 2016 Sep;80(3):477. doi: 10.1002/ana.24741. Epub 2016 Aug 4. No abstract available.

PMID:
27458975
14.

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.

Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, Franques J, Lefebvre MN, Ghorab K, Al-Moussawi M, Tiffreau V, Preudhomme M, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Gilbert W, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Grès C, Nabirotchkin S, Guedj M, Chumakov I, Cohen D.

Orphanet J Rare Dis. 2016 Jul 7;11(1):92. No abstract available.

15.

Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies.

Vallat JM, Magy L, Ciron J, Corcia P, Le Masson G, Mathis S.

Expert Rev Neurother. 2016 Sep;16(9):1111-9. doi: 10.1080/14737175.2016.1198257. Epub 2016 Jun 16. Review.

PMID:
27267749
16.

Classifications of neurogenetic diseases: An increasingly complex problem.

Vallat JM, Goizet C, Tazir M, Couratier P, Magy L, Mathis S.

Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):339-49. doi: 10.1016/j.neurol.2016.04.005. Epub 2016 May 27. Review.

PMID:
27240993
17.

Congenital hypomyelinating neuropathy due to the association of a truncating mutation in PMP22 with the classical HNPP deletion.

Jouaud M, Gonnaud PM, Richard L, Latour P, Ollagnon-Roman E, Sturtz F, Mathis S, Magy L, Vallat JM.

Neuromuscul Disord. 2016 Apr-May;26(4-5):316-21. doi: 10.1016/j.nmd.2016.01.004. Epub 2016 Apr 5.

PMID:
27067623
18.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29.

19.

Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies.

Antoine JC, Robert-Varvat F, Maisonobe T, Créange A, Franques J, Mathis S, Delmont E, Kuntzer T, Lefaucheur JP, Pouget J, Viala K, Desnuelle C, Echaniz-Laguna A, Rotolo F, Camdessanché JP; French Neuromuscular Network FILNEMUS.

J Neurol Sci. 2016 Feb 15;361:187-91. doi: 10.1016/j.jns.2015.12.044. Epub 2015 Dec 29.

PMID:
26810539
20.

Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.

Mathis S, Vallat JM, Magy L.

Immunotherapy. 2016 Feb;8(2):165-78. doi: 10.2217/imt.15.107. Epub 2016 Jan 25. Review.

PMID:
26809024

Supplemental Content

Loading ...
Support Center